Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
British Journal of Clinical Pharmacology|April 19, 2026
HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)Lucy Galloway, Cinzia Dello Russo, Nicholas Bass, et al.
Nature Genetics|June 27, 2017
The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disabilityTarjinder Singh, James T R Walters, Mandy Johnstone, et al.
Translational Psychiatry|November 21, 2025
Effect of polygenic scores on the relationship between psychosis and cognitionLauren Varney, Krisztina Jedlovszky, Baihan Wang, et al.
The Lancet. Neurology|May 17, 2024
Climate change and disorders of the nervous systemSanjay M Sisodiya, Medine I Gulcebi, Francesco Fortunato, et al.
British Journal of Clinical Pharmacology|May 13, 2026
ACKR1/Duffy-null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)Stephen Murtough, Oriella Stellakis, Daisy Mills, et al.
Biological Psychiatry|October 19, 2010
Candidate gene analysis of the human natural killer-1 carbohydrate pathway and perineuronal nets in schizophrenia: B3GAT2 is associated with disease risk and cortical surface areaAnna K Kähler, Srdjan Djurovic, Lars M Rimol, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 17, 2018
Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disordersMaria Stella Calafato, Johan H Thygesen, Siri Ranlund, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 30, 2017
A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domainsSiri Ranlund, Stella Calafato, Johan H Thygesen, et al.
The Pharmacogenomics Journal|January 20, 2026
Pharmacogenomics to optimise psychotropic prescribing: a survey of mental health professionals' perceptions, knowledge, and educational needsDaniele Panconesi, Stephen Murtough, Marius Cotic, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Effect of CYP1A2, CYP2D6, and CYP3A4 Variation on Antipsychotic Treatment OutcomesLauren Varney, Stephen Murtough, Marius Cotic, et al.
Pageof 15